Skip to main content
. 2014 Sep 25;9(9):e103482. doi: 10.1371/journal.pone.0103482

Figure 4. The protein level of galectin-3 was reduced after shRNA treatment.

Figure 4

Three independent shRNAs against galectin-3 were used to construct stable cell lines.